BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26957003)

  • 1. MRI and FDG-PET/CT imaging in gynecological malignancies: the radiation oncology perspective.
    Fennell J; Scholber J; Grosu AL; Volegova-Neher N; Henne K; Langer M; Meyer PT; Gitsch G; Bartl N
    Q J Nucl Med Mol Imaging; 2016 Jun; 60(2):117-23. PubMed ID: 26957003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer.
    Khiewvan B; Torigian DA; Emamzadehfard S; Paydary K; Salavati A; Houshmand S; Shamchi SP; Werner TJ; Aydin A; Roy SG; Alavi A; Kumar R
    Hell J Nucl Med; 2016; 19(3):254-268. PubMed ID: 27824966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of PET Imaging in Gynecologic Radiation Oncology.
    Rao YJ; Grigsby PW
    PET Clin; 2018 Apr; 13(2):225-237. PubMed ID: 29482751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography in gynecological malignancies.
    Kumar R; Chauhan A; Jana S; Dadparvar S
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1033-44. PubMed ID: 16831075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of
    Narayanan P; Sahdev A
    Br J Radiol; 2017 Nov; 90(1079):20170283. PubMed ID: 28830238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality Imaging of Uterine Cervical Malignancies.
    Mansoori B; Khatri G; Rivera-Colón G; Albuquerque K; Lea J; Pinho DF
    AJR Am J Roentgenol; 2020 Aug; 215(2):292-304. PubMed ID: 32551909
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of FDG-PET in cervical cancer and endometrial cancer: utility and future prospects.
    Nogami Y; Iida M; Banno K; Kisu I; Adachi M; Nakamura K; Umene K; Masuda K; Tominaga E; Tanaka K; Aoki D
    Anticancer Res; 2014 Feb; 34(2):585-92. PubMed ID: 24510987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy--tumor volume and FDG uptake value.
    Sakurai H; Suzuki Y; Nonaka T; Ishikawa H; Shioya M; Kiyohara H; Katoh H; Nakayama Y; Hasegawa M; Nakano T
    Gynecol Oncol; 2006 Mar; 100(3):601-7. PubMed ID: 16257440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT in the evaluation of cancer cervix: Where do we stand today?
    Palaniswamy SS; Borde CR; Subramanyam P
    Nucl Med Commun; 2018 Jul; 39(7):583-592. PubMed ID: 29683929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG-PET in carcinoma of the uterine cervix with endometrial extension.
    Hope AJ; Saha P; Grigsby PW
    Cancer; 2006 Jan; 106(1):196-200. PubMed ID: 16302228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evidence on PET-CT for radiation therapy planning in cervix and endometrial cancers.
    Haie-Meder C; Mazeron R; Magné N
    Radiother Oncol; 2010 Sep; 96(3):351-5. PubMed ID: 20709417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Assessment of Gynecologic Malignancies.
    Tripathy S; Parida GK; Kumar R
    PET Clin; 2018 Apr; 13(2):269-288. PubMed ID: 29482754
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
    Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
    Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.
    Tsai CS; Chang TC; Lai CH; Tsai CC; Ng KK; Hsueh S; Yen TC; Hong JH
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1506-12. PubMed ID: 15050330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging to optimize gynecological radiation oncology.
    Kidd EA
    Int J Gynecol Cancer; 2022 Mar; 32(3):358-365. PubMed ID: 35256424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer: comparison with MRI findings.
    Lv K; Guo HM; Lu YJ; Wu ZX; Zhang K; Han JK
    Nucl Med Commun; 2014 Dec; 35(12):1204-11. PubMed ID: 25222911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of uterine cancer.
    Akin O; Mironov S; Pandit-Taskar N; Hann LE
    Radiol Clin North Am; 2007 Jan; 45(1):167-82. PubMed ID: 17157628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of magnetic resonance imaging and positron emission tomography/computed tomography in preoperative lymph node detection of uterine cervical cancer.
    Chung HH; Kang KW; Cho JY; Kim JW; Park NH; Song YS; Kim SH; Chung JK; Kang SB
    Am J Obstet Gynecol; 2010 Aug; 203(2):156.e1-5. PubMed ID: 20435285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
    Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
    Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.